Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
|
|
Hepion Pharmaceuticals, Inc. (CTRV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/08/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 04/28/2021 |
10-K/A
| Annual Report for the period ended December 31, 2020 [amend] |
| 03/31/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 06/15/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
| 05/14/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 03/13/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 03/23/2018 |
10-KT
| Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]: |
| 09/28/2017 |
10-K
| Annual Report for the period ended June 30, 2017 |
| 09/28/2016 |
10-K
| Annual Report for the period ended June 30, 2016 |
| 09/25/2015 |
10-K
| Annual Report for the period ended June 30, 2015 |
| 11/07/2014 |
10-K/A
| Annual Report for the period ended June 30, 2014 [amend] |
| 09/29/2014 |
10-K
| Annual Report for the period ended June 30, 2014 |
|
|